Corrigendum to “Design, synthesis, and evaluation of N-phenyl-4-(2-phenylsulfonamido)-benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response” [Eur J Med Chem. 192 2020 112158] (European Journal of Medicinal Chemistry (2020) 192, (S0223523420301252), (10.1016/j.ejmech.2020.112158))

Wei Cheng Wu, Yi Min Liu, Mei Hsiang Lin, Yu Hsuan Liao, Mei Jung Lai, Hsun Yueh Chuang, To Yu Hung, Chun Han Chen, Jing Ping Liou

Research output: Contribution to journalComment/debate

Abstract

The authors regret that the affiliation of the second corresponding author (C.-H. Chen) in the footnote of pdf version of this article was misplaced. The correct version should be: The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number112329
JournalEuropean Journal of Medicinal Chemistry
Volume196
DOIs
Publication statusPublished - Jun 15 2020

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Corrigendum to “Design, synthesis, and evaluation of N-phenyl-4-(2-phenylsulfonamido)-benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response” [Eur J Med Chem. 192 2020 112158] (European Journal of Medicinal Chemistry (2020) 192, (S0223523420301252), (10.1016/j.ejmech.2020.112158))'. Together they form a unique fingerprint.

  • Cite this